These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 30987527)
1. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study. Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527 [TBL] [Abstract][Full Text] [Related]
2. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. Ito A; Shintaku I; Satoh M; Ioritani N; Aizawa M; Tochigi T; Kawamura S; Aoki H; Numata I; Takeda A; Namiki S; Namima T; Ikeda Y; Kambe K; Kyan A; Ueno S; Orikasa K; Katoh S; Adachi H; Tokuyama S; Ishidoya S; Yamaguchi T; Arai Y J Clin Oncol; 2013 Apr; 31(11):1422-7. PubMed ID: 23460707 [TBL] [Abstract][Full Text] [Related]
3. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial. Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y; Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504 [TBL] [Abstract][Full Text] [Related]
4. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. Yuan H; Mao X; Bai Y; Li H; Liu L; Pu C; Li J; Tang Y; Wei Q; Han P J Chemother; 2015 Aug; 27(4):195-200. PubMed ID: 25968487 [TBL] [Abstract][Full Text] [Related]
5. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833 [TBL] [Abstract][Full Text] [Related]
6. Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma. Lee JH; Lee CU; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Sung HH Cancer Res Treat; 2024 Jul; 56(3):877-884. PubMed ID: 38271926 [TBL] [Abstract][Full Text] [Related]
7. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711 [TBL] [Abstract][Full Text] [Related]
8. A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III). Miyamoto K; Ito A; Wakabayashi M; Eba J; Arai Y; Nishiyama H; Sugimoto M; Yamashita R; Kakehi Y Jpn J Clin Oncol; 2018 Jan; 48(1):94-97. PubMed ID: 29136187 [TBL] [Abstract][Full Text] [Related]
10. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma. Hwang EC; Sathianathen NJ; Jung JH; Kim MH; Dahm P; Risk MC Cochrane Database Syst Rev; 2019 May; 5(5):CD013160. PubMed ID: 31102534 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder]. Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich MG Urologe A; 2008 May; 47(5):608-15. PubMed ID: 18317718 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis. Wu P; Zhu G; Wei D; Liu S; Walsh K; Li D; Harron U; Wang X; Ma H; Wan B; Sun L; Yang Z; Wang J J BUON; 2015; 20(5):1229-38. PubMed ID: 26537069 [TBL] [Abstract][Full Text] [Related]
13. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531 [TBL] [Abstract][Full Text] [Related]
14. Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy. Maeyama R; Ikeda M; Shimura S; Amano N; Murakami Y; Yamada Y; Koguchi D; Tachibana T; Kawamura M; Sakata Y; Hagiwara M; Matsumoto K; Iwamura M Chemotherapy; 2023; 68(4):190-196. PubMed ID: 35390791 [TBL] [Abstract][Full Text] [Related]
15. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations? Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K; BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. Fang D; Li XS; Xiong GY; Yao L; He ZS; Zhou LQ Urol Int; 2013; 91(3):291-6. PubMed ID: 23948770 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy. Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A BMC Urol; 2015 May; 15():45. PubMed ID: 26018765 [TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy. Long X; Zu X; Li Y; He W; Hu X; Tong S; Wang Z; Chen M; Qi L PLoS One; 2016; 11(11):e0166884. PubMed ID: 27870887 [TBL] [Abstract][Full Text] [Related]
20. Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma. Fan B; Teng Q; Sun M; Wang Y; Wang Y; Lin Z; Wang Y; Duan X; Zhang L; Chen T; Chen S; Tai Y; Zhang C; Song X; Liu Z J Oncol; 2022; 2022():1755368. PubMed ID: 35677889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]